Capital Research Global Investors Abb Vie Inc. Transaction History

Capital Research Global Investors

$428 Billion
Q1 2024

A detailed history of Capital Research Global Investors transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Research Global Investors holds 31,295,150 shares of ABBV stock, worth $5.05 Billion. This represents 1.33% of its overall portfolio holdings.

Number of Shares

31,295,150

Previous 30,302,654 3.28%

Holding current value

$5.05 Billion

Previous $4.7 Billion 21.36%

% of portfolio

1.33%

Previous 1.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $159 Million - $181 Million	992,496 Added 3.28%	31,295,150 $5.7 Billion
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $230 Million - $259 Million	-1,673,490 Reduced 5.23%	30,302,654 $4.7 Billion
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $76.1 Million - $88.1 Million	-569,378 Reduced 1.75%	31,976,144 $4.77 Billion
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $420 Million - $523 Million	-3,168,845 Reduced 8.87%	32,545,522 $4.38 Billion
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $144 Million - $166 Million	-997,422 Reduced 2.72%	35,714,367 $5.69 Billion

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $71.7 Million - $86 Million	518,687 Added 1.43%	36,711,789 $5.94 Billion
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $1.33 Billion - $1.52 Billion	9,896,885 Added 37.64%	36,193,102 $4.86 Billion
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.27 Billion - $1.61 Billion	9,216,006 Added 53.96%	26,296,217 $4.03 Billion
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $122 Million - $152 Million	-925,618 Reduced 5.14%	17,080,211 $2.77 Billion
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $108 Million - $136 Million	-1,004,082 Reduced 5.28%	18,005,829 $2.44 Billion
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $34.5 Million - $39.2 Million	324,445 Added 1.74%	19,009,911 $2.05 Billion
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $162 Million - $180 Million	-1,535,173 Reduced 7.59%	18,685,466 $2.1 Billion
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $1.81 Billion - $1.99 Billion	-17,700,423 Reduced 46.68%	20,220,639 $2.19 Billion
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $232 Million - $313 Million	-2,883,051 Reduced 7.07%	37,921,062 $4.06 Billion
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $455 Million - $534 Million	-5,299,576 Reduced 11.49%	40,804,113 $3.57 Billion
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $230 Million - $307 Million	-3,128,616 Reduced 6.35%	46,103,689 $4.53 Billion
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $2.41 Billion - $3.65 Billion	-37,370,388 Reduced 43.15%	49,232,305 $3.75 Billion
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $1.01 Billion - $1.26 Billion	-14,011,979 Reduced 13.93%	86,602,693 $7.67 Billion
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $599 Million - $720 Million	-9,509,347 Reduced 8.64%	100,614,672 $7.62 Billion
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.39 Billion - $3.06 Billion	-36,384,326 Reduced 24.83%	110,124,019 $8.01 Billion
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $2.09 Billion - $2.46 Billion	-27,059,898 Reduced 15.59%	146,508,345 $11.8 Billion
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $200 Million - $247 Million	-2,571,964 Reduced 1.46%	173,568,243 $16 Billion
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.57 Billion - $1.74 Billion	-17,628,648 Reduced 9.1%	176,140,207 $16.7 Billion
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $61.6 Million - $72.9 Million	686,114 Added 0.36%	193,768,855 $18 Billion
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $6.62 Million - $8.87 Million	71,968 Added 0.04%	193,082,741 $18.3 Billion
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $358 Million - $392 Million	3,995,594 Added 2.11%	193,010,773 $18.7 Billion
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $13.2 Billion - $16.9 Billion	189,015,179	189,015,179 $16.8 Billion

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Abb Vie Inc. Transaction History